ARS Pharmaceuticals, Inc. revenue breakdown overview

ARS Pharmaceuticals, Inc. revenue for the last year amounted to 89.15 M USD, the most of which — 89.15 M USD — came from its highest performing source at the moment, Needle-free Epinephrine, the year earlier bringing 30.00 k USD. The greatest contribution to the revenue figure was made by United States — last year it brought ARS Pharmaceuticals, Inc. 89.15 M USD, and the year before that — 30.00 k USD.